000 01275nam a2200349 a 4500
001 EBC802460
003 MiAaPQ
005 20240120132941.0
006 m o d |
007 cr cn|||||||||
008 111119s2012 enka sb 001 0 eng d
020 _z9780123919113
020 _a9780123919137 (electronic bk.)
035 _a(MiAaPQ)EBC802460
035 _a(Au-PeEL)EBL802460
035 _a(CaPaEBR)ebr10509955
035 _a(OCoLC)763157847
040 _aMiAaPQ
_cMiAaPQ
_dMiAaPQ
050 4 _aR853.C55
_bB76 2012
100 1 _aBrody, Tom.
245 1 0 _aClinical trials
_h[electronic resource] :
_bstudy design, endpoints and biomarkers, drug safety, FDA and ICH guidelines /
_cTom Brody.
250 _a1st ed.
260 _aLondon :
_bAcademic Press,
_c2012.
300 _axxxiii, 638 p. :
_bill.
504 _aIncludes bibliographical references and index.
533 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aClinical trials.
650 0 _aDrugs
_xTesting.
655 4 _aElectronic books.
710 2 _aProQuest (Firm)
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=802460
_zClick to View
999 _c70999
_d70999